Management Team

Management Team

  • Dr. Wang Hao - Executive Director, Chief Executive Officer and Chief Scientist

    Dr. Wang Hao (“Dr. Wang”) was appointed as an Executive Director and Chief Scientist of the Company in August 2018, and was appointed as the Chief Executive Officer of the Company in October 2020, primarily responsible for overseeing the operation and management of our Group.

    Dr. Wang joined our Group and served as a Deputy General Manager of Taizhou Pharmaceutical since January 2017 and resigned in March 2017. Dr. Wang has over 21 years of experience in the medical and pharmaceutical technology industry and was appointed as a director of Taizhou Pharmaceutical in August 2018 .

    Dr. Wang was awarded twice with the National Award for Science and Technology Progress in December 2011 and December 2007, respectively, the Shanghai Oriental Scholar Professorship in June 2008, and the Shanghai Award for Science and Technology Progress in December 2003.

  • Mr. Li Yunfeng - Executive Director, Chief Executive Officer and Chief Scientist

    Mr. Li Yunfeng (“Mr. Li”) was appointed as an Executive Director, the Chief Financial Officer and Joint Company Secretary of our Company in August 2018, primarily responsible for overseeing the Group’s management of finance, investment and legal work. Mr. Li joined our Group and served as a Deputy General Manager of Taizhou Pharmaceutical since March 2016. Mr. Li has over 17 years of experience in the biotechnology industry.

  • Dr. Li Jing - Executive Director and Vice President

    Dr. Li Jing (“Dr. Li”) was appointed as an Executive Director and Vice President of our Company in August 2018. Dr. Li is primarily responsible for supervising clinical trials and registration affairs of our Group. Dr. Li joined our Group and served as a Deputy General Manager of Taizhou Pharmaceutical since February 2015. Dr. Li has more than 17 years of experience in the biotechnology industry.

    Dr. Li was accredited as a senior pharmaceutical engineer by Guangdong Medical and Pharmaceutical Advanced Professional Qualification Advisory Committee in February 2001. In May 2007, Dr. Li was appointed by Shanghai Municipal Science and Technology Commission as a technology foresight expert in key areas of science and technology development for the year of 2007 to 2008. Dr. Li received Shanghai Municipality's Excellent Discipline Leaders Program (Category B) Scholarship in November 2007. She was also appointed as a member of the Committee of Quality Expert of China Protein Drug Quality Alliance in March 2016, serving the relevant positions from March 2016 to March 2019. In August 2017, Dr. Li was appointed as a member of the Chinese Pharmacopoeia Commission.

  • Mr. Tao Jing - Executive Director and Vice President

    Mr. Tao Jing (“Mr. Tao”) joined Taizhou Pharmaceutical in February 2015 as a Deputy General Manager and was appointed as the Vice President of the Company and General Manager of Taizhou Pharmaceutical in August 2018 and an Executive Director of the Company in October 2020. He is primarily responsible for overseeing the Group’s production of drugs. Mr. Tao received his bachelor degree in Biochemistry from Anhui University in July 1994. He also obtained an advanced certificate in biochemistry from Shanghai Municipal Human Resources and Social Security Bureau in November 2013.

  • Mr. Zhuge Wenhui - Vice President of Sales

    Mr. Zhuge Wenhui (“Mr. Zhuge”) is a Vice President of Sales of the Company since August 2018, primarily responsible for the Group’s marketing and sales channel management. Mr. Zhuge joined our Group in February 2016 and served as a Deputy General Manager of Taizhou Pharmaceutical till January 2017. Mr. Zhuge successively obtained a bachelor degree in medicine from Anhui College of Chinese Medicine (currently known as Anhui University of Chinese Medicine and a master degree in Chinese medicine from Shanghai College of Traditional Chinese Medicine (currently known as Shanghai University of Traditional Chinese Medicine).

Joint Company Secretaries

  • Mr. Li Yunfeng - Executive Director, Chief Financial Officer and Joint Company Secretary

    Mr. Li Yunfeng (“Mr. Li”) was appointed as an Executive Director, Chief Financial Officer and Joint Company Secretary of our Company, primarily responsible for overseeing the Group’s management of finance, investment and legal work. Mr. Li joined our Group and served as a Deputy General Manager of Taizhou Pharmaceutical since March 2016. Mr. Li has over 17 years of experience in the biotechnology industry.

  • Mr. Tsang Ho Yin

    Mr. Tsang Ho Yin (“Mr. Tsang”) was appointed as a Joint Company Secretary of our Company. Mr. Tsang was admitted as a solicitor in Australia and Hong Kong in 2012 and 2013, respectively. Mr. Tsang obtained a Bachelor of laws and a Bachelor of Business Administration (major in Accounting) from University of Melbourne, Australia, Master of Laws from University of Melbourne, Australia, the Postgraduate Certificate in Laws from the City University of Hong Kong and the Graduate Diploma of Legal Practice from College of Law (Victoria), Australia. Mr. Tsang joined Stevenson, Wong & Co. in September 2015 and currently serves as its partner, specialising in corporate finance and commercial law.